Home Abceutics

Abceutics

acquired
-
ADC Drug Developer
Basic
Enterprise Profile

Basic Information

Abceutics is a preclinical biopharmaceutical startup spun out from the laboratory of Professor Joseph P. Balthasar, a researcher at the University at Buffalo in New York. The company's core technology has been licensed from the University at Buffalo.
Abceutics Inc.
NewYork,United States of America
15~50 people
January 01, 2020
--
--

Enterprise Profile

Industrial Sector
New Drug Development Biological Drug Production
Technology
Biotechnology
Concept
Tumor Therapeutic Products
Application Scenarios
Innovative Drugs ADC (Antibody-Drug Conjugate)